ArticleCureus2026
Accessory Breast Apocrine Carcinoma: Report of a Rare Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Axillary apocrine carcinoma may arise from cutaneous adnexal glands or breast tissue, including accessory breast tissue. Accessory breast carcinoma is rare, and apocrine carcinoma represents an uncommon histologic subtype of breast cancer. For accessory breast carcinoma, wide local excision and lymph node dissection is generally recommended. Postoperative therapy, including endocrine therapy, is considered following treatment strategies for breast cancer. We report an extremely rare case of accessory breast apocrine carcinoma (ABAC). To the best of our knowledge, this is the first case documented in the English-language literature. A 57-year-old woman presented with an enlarged cutaneous tumor in the right axilla. Initial excision revealed apocrine carcinoma arising from the cutaneous adnexal glands or accessory breast tissue. Imaging demonstrated axillary lymph node metastasis, and the patient subsequently underwent wide local excision with axillary lymph node dissection. Histopathological examination confirmed accessory breast tissue adjacent to the carcinoma, leading to a diagnosis of ABAC. The tumor showed a triple-negative phenotype, and postoperative radiation therapy was administered. At the five-month follow-up, no recurrence or lymphedema was observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.